Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer

Overview of attention for article published in Annals of Surgical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 26 X users

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 30 X posts from 26 X users, with an upper bound of 81,480 followers.

RT @CarlosHFChan: Is in situ immunization using immunostimulatory virus-like particles the way to treat this deadly disease? 🤞#PeritonealC…

Is in situ immunization using immunostimulatory virus-like particles the way to treat this deadly disease? 🤞#PeritonealCarcinomatosis ⁦@acpmpresearch⁩ ⁦@letswinpc⁩ ⁦@PMPSurvivor⁩ ⁦@PanCAN⁩ https://t.co/ketJRy9JgF

RT @PoHienEar: Very nice work! Big congrats to Dr. Ann Miller, Chan lab and collaborators!

Incredible work from one of my mentors and his team using immuno-oncology in peritoneal carcinomatosis. A hopeful sign for the future! Congrats @CarlosHFChan @UIowa_Surgery

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.